| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | — |
| R&D Expense | $3.3M | +201.0% |
| SG&A Expense | $9.7M | -38.6% |
| Operating Income | -$11.5M | +31.8% |
| Income Tax | $2K | +0.0% |
| Net Income | -$11.4M | +32.0% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.7M | -23.3% |
| Current Assets | $29.5M | -23.1% |
| Total Assets | $33.3M | -16.6% |
| Current Liabilities | $1.4M | +91.8% |
| Total Liabilities | $3.1M | +328.2% |
| Stockholders' Equity | $30.2M | -22.9% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.5M | +36.6% |
| Capital Expenditures | $409K | +1.0% |
| Investing Cash Flow | -$409K | -4.1% |
| Financing Cash Flow | $205K | -99.1% |
| Free Cash Flow | -$8.9M | +35.4% |